Do You Trust Your AI Shopper? Why You Shouldn’t—at Least Not Yet.
The success or failure of bot shoppers is going to come down to trust. So far, the retail establishment has the upper hand.
The New Congress Must Address the $40 Trillion Debt. And Very Soon.
The next generation depends on it. Here are five potential endgames.
The Easy Way to Play China’s Biotech Wave
Many of the hot new drug candidates in the U.S. were developed by Chinese companies. So if you want a piece of the action, buy American names that you know. We give you some suggestions.
Berkshire Buys Back a Chunk of Stock. Buffett and CEO Abel Liked the Price.
The company also disclosed in its earnings release that operating earnings fell 6%. A currency loss tied to yen-related borrowings dragged down the number.
4 minute read
Barron's Live
This Week on Wall Street
Retirement and Well-Being
She’s Caring for Her Dad and Barely Making Ends Meet. She’s Not Alone.
Lory Frenkel and other Americans in their 50s nationwide are caught in a caregiving crisis that’s zapping their retirement savings.
What We're Talking About
Q&A
America 250
What 150 Years of Stock Market Bubbles Teach Us About the AI Boom
This year, Barron’s has published a series of articles linking the birth and growth of America with the rise of financial markets. Today: Observers missed the signs of downturns in 1873, 1929, and 2000. Now, money is pouring into AI faster than it did in those crashes.
Alcoa: A Cheap Stock Play on the Aluminum Market
The aluminum producer may not be what it once was, but there’s plenty of upside for investors.
Long Read
Energy Drinks Are Exploding. Why Is Celsius Stock Fizzling?
The energy-drink industry is growing sales at 15% a year, the fastest in the beverage aisle. But competition is fierce, with each brand staking a claim to niche consumers.
Long Read
Toasters, Data Centers, and an Unassuming Box That’s Boosting 3 Power Stocks
It’s a high-voltage stopgap that just might save the artificial-intelligence buildout.
Long Read
November 9, 2026
The New Congress Must Address the $40 Trillion Debt. And Very Soon.
Five paths forward for resolving the federal debt.
Long Read
Moderna Stock Is Up 700% on Cancer Vaccine Hype
Moderna posts higher-than-expected revenue as results get a lift from international Covid vaccine demand.
3 minute read
Humana’s Costs Are Down. The Stock Is Up.
Humana had a narrower-than-expected quarterly loss, with its Medicare business under pressure.
3 minute read
Half of Our ‘Big Money’ Managers Say the AI Boom Has Years Left to Run
Optimists cite robust earnings growth; the pessimists see a bubble in danger of bursting. Plus, pro forecasts for rates, international markets, the midterm, and more.
Long Read
Don’t Fret the War. Why ‘Big Money’ Investors Are Bullish—and Where They’re Investing Now.
In our latest Big Money poll, professional investors are more upbeat than six months ago and see plenty of opportunities for stocks. Where they’re putting money to work.
Long Read
The BOE Just Hiked Rates for the First Time Since the Iran War Started
The Bank of England follows the Fed and the ECB in hiking rates amid surging energy costs and inflation fears.
1 minute read
Markets Bet Trump Will End the Iran War. That’s Easier Said Than Done.
The U.S. midterms ended with a rejection of an expensive foreign policy.
Long Read
Bank of America’s Holly O’Neill: “I’m Very Bullish on What AI Has in Store for Us”
The president of consumer, retail, and preferred banking at Bank of America speaks with Barron’s about her 30-year career and what’s next for financial innovation.
Long Read
Week’s Best: How to Get In on Anthropic’s IPO
Here’s our weekly roundup of the most-read articles at Barron’s Advisor.
2 minute read
Check out Barron's Advisor Rankings
Barron's ranks the best advisors, firms, and teams in the country. The goal is to shine a spotlight on the nation's best financial advisors, with an eye toward raising standards in the industry.
Find an Advisor
Are you ready to search for a financial advisor? We'll match you with advisors who can help.
Recently Viewed Tickers
SymbolPriceChange% Chg
U.S. Stock Movers
Includes common stocks, ADRs and REITs listed on NYSE, Nasdaq or NYSE American with a prior day close of $2 a share or higher and volume of at least 50,000
| Company (Ticker) | Change Percent | Price |
|---|---|---|
| Gogo Inc. (GOGO) | 71.52% | $3.88 |
| SkinHealth Systems Inc. (SKIN) | 51.79% | $15.71 |
| Obsidian Therapeutics Inc. (OBX) | 44.43% | $13.86 |
| Karman Holdings Inc. (KRMN) | 42.13% | $45.61 |
| Serve Robotics Inc. (SERV) | 38.79% | $3.22 |